Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
The decision framework articulated herein provides a structured approach to this problem, replacing narrative optimism with transparent criteria
The inherent pharmacokinetic limitations of native GLP-1, such as its short biological half-life, have catalyzed significant advancements through in-depth research into its physiology, secretion dynamics, and molecular characteristics
Imodium works by slowing down how quickly the gut moves, which allows the body to absorb more fluids and form firmer stools
The idea of medical freedomthat we should be allowed to decide what to do about our own healthhas long had a special status in the United States
Have lost 6 lbs in 3 weeks and stopped disordered binge eating